These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


173 related items for PubMed ID: 28767587

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Histone deacetylase-1 as a prognostic factor and mediator of gastric cancer progression by enhancing glycolysis.
    Jiang Z, Yang H, Zhang X, Wang Z, Rong R, Wang X.
    Hum Pathol; 2019 Mar; 85():194-201. PubMed ID: 30500418
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. High expression of SNIP1 correlates with poor prognosis in non-small cell lung cancer and SNIP1 interferes with the recruitment of HDAC1 to RB in vitro.
    Jeon HS, Choi YY, Fukuoka J, Fujii M, Lyakh LA, Song SH, Travis WD, Park JY, Jen J.
    Lung Cancer; 2013 Oct; 82(1):24-30. PubMed ID: 23932364
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Bmi-1 overexpression as an efficient prognostic marker in patients with nonsmall cell lung cancer.
    Zhang X, Tian T, Sun W, Liu C, Fang X.
    Medicine (Baltimore); 2017 Jun; 96(26):e7346. PubMed ID: 28658153
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Carbohydrate Antigen 19-9 Is a Prognostic Factor Which Correlates With HDAC1 and HIF-1α for Intrahepatic Cholangiocarcinoma.
    Ohta S, Morine Y, Imura S, Ikemoto T, Arakawa Y, Iwahashi S, Saito YU, Yamada S, Wada Y, Yamashita S, Bando Y, Shimada M.
    Anticancer Res; 2019 Nov; 39(11):6025-6033. PubMed ID: 31704828
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Prognostic impact of elevation of vascular endothelial growth factor family expression in patients with non-small cell lung cancer: an updated meta-analysis.
    Zheng CL, Qiu C, Shen MX, Qu X, Zhang TH, Zhang JH, Du JJ.
    Asian Pac J Cancer Prev; 2015 Nov; 16(5):1881-95. PubMed ID: 25773840
    [Abstract] [Full Text] [Related]

  • 19. Prognostic value of tissue inhibitor of metalloproteinase-2 expression in patients with non-small cell lung cancer: a systematic review and meta-analysis.
    Zhu L, Yu H, Liu SY, Xiao XS, Dong WH, Chen YN, Xu W, Zhu T.
    PLoS One; 2015 Nov; 10(4):e0124230. PubMed ID: 25905787
    [Abstract] [Full Text] [Related]

  • 20. Prognostic and clinicopathological significance of long noncoding RNA MALAT-1 expression in patients with non-small cell lung cancer: A meta-analysis.
    Liu X, Huang G, Zhang J, Zhang L, Liang Z.
    PLoS One; 2020 Nov; 15(10):e0240321. PubMed ID: 33052949
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.